Transgene (France) Buy Hold or Sell Recommendation
| TNG Stock | EUR 1.33 0.05 3.62% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Transgene SA is 'Strong Sell'. Macroaxis provides Transgene buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding TNG positions. The advice algorithm takes into account all of Transgene's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Transgene's buy or sell advice are summarized below:
Real Value 1.09 | Hype Value 1.33 | Market Value 1.33 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Transgene SA given historical horizon and risk tolerance towards Transgene. When Macroaxis issues a 'buy' or 'sell' recommendation for Transgene SA, the advice is generated through an automated system that utilizes algorithms and statistical models.
Transgene |
Execute Transgene Buy or Sell Advice
The Transgene recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Transgene SA. Macroaxis does not own or have any residual interests in Transgene SA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Transgene's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Transgene Trading Alerts and Improvement Suggestions
| Transgene SA may become a speculative penny stock | |
| Transgene SA has a very high chance of going through financial distress in the upcoming years | |
| Transgene SA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 9.99 M. Net Loss for the year was (19.54 M) with loss before overhead, payroll, taxes, and interest of (15.87 M). | |
| Transgene SA has accumulated about 16.9 M in cash with (31.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27. |
Transgene Returns Distribution Density
The distribution of Transgene's historical returns is an attempt to chart the uncertainty of Transgene's future price movements. The chart of the probability distribution of Transgene daily returns describes the distribution of returns around its average expected value. We use Transgene SA price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Transgene returns is essential to provide solid investment advice for Transgene.
| Mean Return | 0.02 | Value At Risk | -3.62 | Potential Upside | 4.42 | Standard Deviation | 2.82 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Transgene historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Transgene Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Transgene or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Transgene's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Transgene stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.09 | |
β | Beta against NYSE Composite | -1.04 | |
σ | Overall volatility | 2.84 | |
Ir | Information ratio | -0.03 |
Transgene Volatility Alert
Transgene SA currently demonstrates below-average downside deviation. It has Information Ratio of -0.03 and Jensen Alpha of 0.09. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Transgene's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Transgene's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Transgene Fundamentals Vs Peers
Comparing Transgene's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Transgene's direct or indirect competition across all of the common fundamentals between Transgene and the related equities. This way, we can detect undervalued stocks with similar characteristics as Transgene or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Transgene's fundamental indicators could also be used in its relative valuation, which is a method of valuing Transgene by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Transgene to competition |
| Fundamentals | Transgene | Peer Average |
| Return On Equity | -0.36 | -0.31 |
| Return On Asset | -0.16 | -0.14 |
| Profit Margin | (1.27) % | (1.27) % |
| Operating Margin | (1.39) % | (5.51) % |
| Current Valuation | 144.73 M | 16.62 B |
| Shares Outstanding | 100.2 M | 571.82 M |
| Shares Owned By Institutions | 1.70 % | 39.21 % |
| Price To Earning | 18.08 X | 28.72 X |
| Price To Book | 3.39 X | 9.51 X |
| Price To Sales | 10.07 X | 11.42 X |
| Revenue | 9.99 M | 9.43 B |
| Gross Profit | (15.87 M) | 27.38 B |
| EBITDA | (16.55 M) | 3.9 B |
| Net Income | (19.54 M) | 570.98 M |
| Cash And Equivalents | 16.9 M | 2.7 B |
| Cash Per Share | 0.27 X | 5.01 X |
| Debt To Equity | 162.30 % | 48.70 % |
| Current Ratio | 1.52 X | 2.16 X |
| Book Value Per Share | 0.55 X | 1.93 K |
| Cash Flow From Operations | (31.94 M) | 971.22 M |
| Earnings Per Share | (0.23) X | 3.12 X |
| Target Price | 4.3 | |
| Number Of Employees | 143 | 18.84 K |
| Beta | 0.79 | -0.15 |
| Market Capitalization | 205.42 M | 19.03 B |
| Total Asset | 101.84 M | 29.47 B |
| Retained Earnings | (538 M) | 9.33 B |
| Working Capital | 24 M | 1.48 B |
| Current Asset | 51 M | 9.34 B |
| Current Liabilities | 27 M | 7.9 B |
| Z Score | -7.0 | 8.72 |
| Net Asset | 101.84 M |
Transgene Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Transgene . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Transgene Buy or Sell Advice
When is the right time to buy or sell Transgene SA? Buying financial instruments such as Transgene Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Transgene in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Silver Thematic Idea Now
Silver
Companies involved in mining, production, and distribution of silver and silver goods. The Silver theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Silver Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Transgene Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Transgene SA information on this page should be used as a complementary analysis to other Transgene's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Transgene Stock analysis
When running Transgene's price analysis, check to measure Transgene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Transgene is operating at the current time. Most of Transgene's value examination focuses on studying past and present price action to predict the probability of Transgene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Transgene's price. Additionally, you may evaluate how the addition of Transgene to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |